🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

The Safe Fast Track Study

RecruitingNAAges 18 Years - anyAllOdense University Hospital
NCT06219486 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Emergency departments (ED) internationally are treating an increasing number of patients. Most require hospital services but some could be better cared for on alternative pathways. D-dimer has some unique properties. It is non-specific and is elevated in many acute condi- tions; but conversely remains normal in the absence of significant disease. Previous studies have shown that having a normal D-dimer on arrival to the emergency department is associated with a very low risk of 30-day all-cause mortality. The investigators propose a multicenter randomized controlled trial using D-dimer to identify patients at low risk and test if providing this information will change time to discharge disposition by the treating physician.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age 18 or above * Able to provide oral and written informed consent in Danish * Blood tests ordered on arrival as part of standard of care * Ambulatory on arrival or walking to the ambulance (i.e., stable independent gait) * Normal vital signs (i.e., National Early Warning Score \< 3) Exclusion Criteria: * Unstable condition requiring immediate care in the resuscitation area * Triage level red (i.e., the most urgent patients) * Trauma (minor and major) patients * High likelihood of requiring a D-dimer analysis on clinical indications during the current hospital contact (e.g., suspected venous thromboembolic disease) that will be ordered on arrival regardless of this study * Previous participation in the study
💊

What it tests

  • D-dimer
📍

Where

2 sites
Esbjerg Hospital
Esbjerg, Denmark
Odense University Hospital
Odense, Denmark
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy